Profile data is unavailable for this security.
About the company
Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is engaged in the operation of chain pharmacy stores. Other Business segment is engaged in the distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products.
- Revenue in HKD (TTM)634.87bn
- Net income in HKD9.31bn
- Incorporated2003
- Employees113.64k
- LocationSinopharm Group Co LtdSinopharm Group Building, No. 385, EastSHANGHAI 200023ChinaCHN
- Phone+86 2 123052666
- Fax+86 2 123052888
- Websitehttps://www.sinopharmgroup.com.cn/
| Holder | Shares | % Held |
|---|---|---|
| Lazard Asset Management LLCas of 20 Sep 2024 | 114.70m | 8.55% |
| Fidelity Management & Research Co. LLCas of 20 Sep 2024 | 82.51m | 6.15% |
| JPMorgan Asset Management (Asia Pacific) Ltd.as of 14 Nov 2024 | 51.71m | 3.85% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 47.67m | 3.55% |
| Dimensional Fund Advisors LPas of 07 Nov 2024 | 26.66m | 1.99% |
| FIAM LLCas of 24 Sep 2024 | 26.59m | 1.98% |
| BlackRock Fund Advisorsas of 13 Nov 2024 | 23.85m | 1.78% |
| Fidelity Investments Canada ULCas of 30 Sep 2024 | 19.47m | 1.45% |
| Wasatch Advisors LPas of 31 Mar 2024 | 18.29m | 1.36% |
| Hang Seng Investment Management Ltd.as of 08 Nov 2024 | 16.65m | 1.24% |
